top of page
LATEST NEWS
LIfT BioSciences raises £10m in first close of Series A to advance first-in-class allogeneic innate cell therapy
LIfT BioSciences raises £10m in first close of Series A to advance first-in-class allogeneic innate cell therapy
Sep 24, 2024
Tony De Fougerolles shares his experiences in developing industry-disrupting technologies, meeting LIfT’s CEO Alex Blyth, and his reasons for becoming Chairman of LIfT’s Board of Directors
In this interview, Tony de Fougerolles describes his extensive experience in building out drug pipelines in the US and Europe, including...
Jul 24, 2024
LIfT BioSciences appoints Antonin (Tony) de Fougerolles as Chairman of its Board of Directors
London, 1 July 2024– LIfT BioSciences, (‘LIfT’ or ‘the Company’), a rapidly emerging biotech company preparing to start clinical trials...
Jul 1, 2024
bottom of page